EDIT experienced severe financial deterioration with stockholders' equity collapsing 79.7% to just $27.3M while dramatically cutting R&D spending by 54.9%, signaling potential liquidity concerns and strategic pivot away from broad development programs.
The massive decline in stockholders' equity to $27.3M combined with continued operating losses of $160M annually suggests EDIT is approaching a critical financial juncture that may require immediate capital raising or strategic alternatives. The company's shift to focusing exclusively on lead candidate EDIT-401 and the 55% reduction in R&D spending indicates a forced narrowing of its pipeline to preserve cash, which reduces diversification and increases concentration risk.
EDIT's financials show a company in severe distress, with stockholders' equity plummeting 79.7% to just $27.3M while total assets declined 45.4% to $186.5M, indicating significant cash burn and potential dilutive financing. Although operating cash flow improved 21.4% and R&D expenses were slashed 54.9%, the company continues burning substantial cash with $160M in operating losses, creating an urgent need for capital. The dramatic reduction in capital expenditures from $8.8M to $607K further signals cost-cutting measures as the company likely approaches a financial inflection point.
Capex reduced 93.1% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.
R&D spending cut 54.9% — could signal cost discipline or concerning reduction in innovation investment.
Total assets contracted 45.4% — asset sales, write-downs, or balance sheet optimization underway.
Current assets declined 43.4% — monitor working capital adequacy and short-term liquidity.
Current liabilities reduced — improved short-term financial position and working capital health.
Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.
Net income grew 32.5% — bottom-line growth signals improving overall business health.
Liabilities reduced 23.2% — deleveraging improves balance sheet strength and financial flexibility.
Operating cash flow grew 21.4% — strong conversion of earnings to cash, healthy business fundamentals.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →